1. Home
  2. KRO vs OMER Comparison

KRO vs OMER Comparison

Compare KRO & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRO
  • OMER
  • Stock Information
  • Founded
  • KRO 1916
  • OMER 1994
  • Country
  • KRO United States
  • OMER United States
  • Employees
  • KRO N/A
  • OMER N/A
  • Industry
  • KRO Major Chemicals
  • OMER Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRO Industrials
  • OMER Health Care
  • Exchange
  • KRO Nasdaq
  • OMER Nasdaq
  • Market Cap
  • KRO 590.2M
  • OMER 513.8M
  • IPO Year
  • KRO N/A
  • OMER 2009
  • Fundamental
  • Price
  • KRO $4.73
  • OMER $7.17
  • Analyst Decision
  • KRO Strong Sell
  • OMER Strong Buy
  • Analyst Count
  • KRO 2
  • OMER 6
  • Target Price
  • KRO $6.50
  • OMER $27.50
  • AVG Volume (30 Days)
  • KRO 272.8K
  • OMER 8.3M
  • Earning Date
  • KRO 11-06-2025
  • OMER 11-07-2025
  • Dividend Yield
  • KRO 4.23%
  • OMER N/A
  • EPS Growth
  • KRO 3452.79
  • OMER N/A
  • EPS
  • KRO 0.59
  • OMER N/A
  • Revenue
  • KRO $1,892,000,000.00
  • OMER N/A
  • Revenue This Year
  • KRO N/A
  • OMER N/A
  • Revenue Next Year
  • KRO $6.29
  • OMER N/A
  • P/E Ratio
  • KRO $8.06
  • OMER N/A
  • Revenue Growth
  • KRO 6.51
  • OMER N/A
  • 52 Week Low
  • KRO $4.70
  • OMER $2.95
  • 52 Week High
  • KRO $12.98
  • OMER $13.60
  • Technical
  • Relative Strength Index (RSI)
  • KRO 35.94
  • OMER 55.84
  • Support Level
  • KRO $4.70
  • OMER $7.44
  • Resistance Level
  • KRO $4.96
  • OMER $8.05
  • Average True Range (ATR)
  • KRO 0.21
  • OMER 0.77
  • MACD
  • KRO 0.01
  • OMER -0.12
  • Stochastic Oscillator
  • KRO 3.85
  • OMER 1.99

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: